Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04810858 · ClinicalTrials.gov registry record · NA

Modeling the Effects of Chronic Marijuana Use on Neuroinflammation and HIV-related Neuronal Injury

A NA study of HIV and Inflammation, sponsored by Wake Forest University Health Sciences.

Recruiting
Registry status
NA
Development phase
220
Enrollment target
1
Study location

NCT04810858 is a NA study of HIV and Inflammation that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 220 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04810858, a NA study of HIV and Inflammation, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.

RECRUITING
Registry status
NA
Development phase
220 participants
Enrollment target
1
Study location

Study Summary

This study applies a hypothesis-driven approach to examine the effects of chronic marijuana use on HIV-associated inflammation and its subsequent impacts on central nervous system function, with the goal of identifying the mechanisms through which cannabinoids modulate neurological disorders and other comorbidities in persons with HIV.

Interventions

  • OTHER Multimodal, multi-parametric MRI
  • OTHER Immune and cytokine profiling
  • BEHAVIORAL Neuropsychological testing

Study Locations (1)

North Carolina

  • Biotech Place - Winston-Salem

Trial Details

FieldValue
Enrollment Target 220 participants
Start Date 2021-08-18
Est. Completion 2026-05-31
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT04810858

The ClinicalTrials.gov registry entry for NCT04810858 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 303 other HIV trials with a reported enrollment target (50% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with HIV appearing as the primary indexed condition, and to 3 interventions - of which Multimodal, multi-parametric MRI is the first listed.

NCT04810858 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT04810858 about?

NCT04810858 is a clinical study titled "Modeling the Effects of Chronic Marijuana Use on Neuroinflammation and HIV-related Neuronal Injury". This study applies a hypothesis-driven approach to examine the effects of chronic marijuana use on HIV-associated inflammation and its subsequent impacts on central nervous system function, with the goal of identifying the mechanisms through which cannabinoids modulate neurological disorders and oth...

What is the current status of trial NCT04810858?

This trial is currently recruiting. It is a NA study. The enrollment target is 220 participants. The study started on 2021-08-18. Estimated completion is 2026-05-31.

What conditions does trial NCT04810858 study?

This clinical trial studies the following conditions: HIV, Inflammation, Cognition, Cannabis, Neuroimaging.

What interventions are being tested in trial NCT04810858?

The interventions under investigation include: Multimodal, multi-parametric MRI (OTHER), Immune and cytokine profiling (OTHER), Neuropsychological testing (BEHAVIORAL).

Who is sponsoring clinical trial NCT04810858?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04810858 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.